Literature DB >> 33673369

Botulinum Neurotoxin Injections in Childhood Opisthotonus.

Mariam Hull1,2, Mered Parnes1,2, Joseph Jankovic2.   

Abstract

Opisthotonus refers to abnormal axial extension and arching of the trunk produced by excessive contractions of the paraspinal muscles. In childhood, the abnormal posture is most often related to dystonia in the setting of hypoxic injury or a number of other acquired and genetic etiologies. The condition is often painful, interferes with ambulation and quality of life, and is challenging to treat. Therapeutic options include oral benzodiazepines, oral and intrathecal baclofen, botulinum neurotoxin injections, and deep brain stimulation. Management of opisthotonus within the pediatric population has not been systematically reviewed. Here, we describe a series of seven children who presented to our institution with opisthotonus in whom symptom relief was achieved following administration of botulinum neurotoxin injections.

Entities:  

Keywords:  axial dystonia; botulinum toxin; opisthotonos; opisthotonus

Mesh:

Substances:

Year:  2021        PMID: 33673369      PMCID: PMC7918608          DOI: 10.3390/toxins13020137

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  55 in total

1.  Intrathecal baclofen for dystonia.

Authors:  J G Hou; W Ondo; J Jankovic
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

2.  Dopa-responsive dystonia with a novel initiation codon mutation in the GCH1 gene misdiagnosed as cerebral palsy.

Authors:  Jae-Hyeok Lee; Chang-Seok Ki; Dae-Seong Kim; Jae-Wook Cho; Kyung-Phil Park; Seonhye Kim
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

Review 3.  Botulinum toxin: State of the art.

Authors:  Joseph Jankovic
Journal:  Mov Disord       Date:  2017-06-22       Impact factor: 10.338

4.  Status dystonicus: Diagnosis and management of a rare and challenging entity.

Authors:  Prince Thakkar; Naveen B P; Sangeetha Yoganathan; Judy Ann John; Maya Thomas
Journal:  J Pediatr Rehabil Med       Date:  2019

5.  The natural history of tardive dystonia. A long-term follow-up study of 107 cases.

Authors:  V Kiriakakis; K P Bhatia; N P Quinn; C D Marsden
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

6.  L-Glutaric acidemia: investigation of a patient and his family.

Authors:  D T Whelan; R Hill; E D Ryan; M Spate
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

Review 7.  An update on new and unique uses of botulinum toxin in movement disorders.

Authors:  Joseph Jankovic
Journal:  Toxicon       Date:  2017-09-06       Impact factor: 3.033

Review 8.  Status dystonicus: a practice guide.

Authors:  Nicholas M Allen; Jean-Pierre Lin; Tim Lynch; Mary D King
Journal:  Dev Med Child Neurol       Date:  2013-12-04       Impact factor: 5.449

Review 9.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

10.  Titration of high dose sedation is effective in severe tetanus: a case report.

Authors:  Pan Chun; Huang Ying-Zi; Yang Yi; Qiu Hai-Bo
Journal:  Cases J       Date:  2009-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.